RISK OF DEATH AFTER PACLITAXEL EXPOSURE DURING FEMOROPOPLITEAL ARTERY ANGIOPLASTY – NARRATIVE REVIEW

RISK OF DEATH AFTER PACLITAXEL EXPOSURE DURING FEMOROPOPLITEAL ARTERY ANGIOPLASTY – NARRATIVE REVIEW

Paclitaxel molecule has been on the market since 1991 and is indicated for the treatment of multiple neoplasms. Since 2012 has been used in endovascular devices for the treatment of peripheral artery disease and have become a mainstay in the treatment of symptomatic femoro-popliteal lesions, in...

Full description

Bibliographic Details
Main Authors: Tiago F. Ribeiro, Rita Soares Ferreira, Joana Cardoso, Adriana Figueiredo, Helena Fidalgo, Frederico Bastos Gonçalves, Maria Emília Ferreira
Format: Article
Language:Portuguese
Published: Sociedade Portuguesa de Angiologia e Cirurgia Vascular 2022-03-01
Series:Angiologia e Cirurgia Vascular
Subjects:
Peripheral Artery Disease
Endovascular Therapy
Paclitaxel Coated Devices
Online Access:https://acvjournal.com/index.php/acv/article/view/436

Internet

https://acvjournal.com/index.php/acv/article/view/436

Similar Items